A hypoxia-inducible vigilant vector system for activating therapeutic genes in ischemia
Open Access
- 31 March 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 12 (15), 1163-1170
- https://doi.org/10.1038/sj.gt.3302513
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Protection From Ischemic Heart Injury by a Vigilant Heme Oxygenase-1 Plasmid SystemHypertension, 2004
- Absence of heme oxygenase‐1 exacerbates atherosclerotic lesion formation and vascular remodelingThe FASEB Journal, 2003
- Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularizationGene Therapy, 2003
- Hypoxia-mediated tumour targetingGene Therapy, 2003
- Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemiaGene Therapy, 2003
- Novel chimeric gene promoters responsive to hypoxia and ionizing radiationGene Therapy, 2002
- HIF‐1 is expressed in normoxic tissue and displays an organ‐specific regulation under systemic hypoxiaThe FASEB Journal, 2001
- Accumulation of HIF-1α under the influence of nitric oxideBlood, 2001
- Characterization of Physiologically Regulated Vectors for the Treatment of Ischemic DiseaseHuman Gene Therapy, 1999
- Time from onset of symptoms to thrombolytic therapy: A major determinant of myocardial salvage in patients with acute transmural infarctionJournal of the American College of Cardiology, 1985